MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dementia"

  • 2026 International Congress

    Cognitive Profile In Indian Patients with Spinocerebellar Ataxia (SCA) – Prospective Cross-sectional Study

    A. Patel, M. Bhatt, A. Aggarwal (Mumbai, India)

    Objective: To evaluate the prevalence, spectrum, and severity of cognitive impairment in Indian patients with genetically confirmed SCA and corelate with motor severity. Background: Beyond…
  • 2026 International Congress

    Differences in Lewy body dementia in people from ethnic minorities: a systematic review of epidemiology, diagnosis, clinical features and imaging

    S. Kalam, A. Zirra, J. Knight, L. Bishop, R. Fernando, C. Marshall, A. Noyce, R. Weil (London, United Kingdom)

    Objective: To systematically review evidence on epidemiological and clinical differences in Lewy body dementia (LBD), including dementia with Lewy bodies (DLB) and Parkinson’s disease dementia…
  • 2026 International Congress

    [18F]-FDG-PET metabolic phenotyping in idiopathic normal pressure hydrocephalus: visual and voxel-wise evidence across neurodegenerative phenotypes

    C. Espinoza-Vinces, E. Prieto-Azcárate, I. Avilés-Olmos, J. Núñez-Córdoba, J. Arbizu, M. Luquin (Pamplona, Spain)

    Objective: To characterise FDG-PET metabolic phenotypes in idiopathic normal pressure hydrocephalus (iNPH) using integrated visual and voxel-wise analyses. Background: iNPH is a potentially treatable cause…
  • 2026 International Congress

    A Novel Case of Persistent Singing in Progressive Supranuclear Palsy

    F. Chinea, U. Akbar (Hackensack, USA)

    Objective: To present a unique case of a person with progressive supranuclear palsy (PSP) who developed persistent singing, and review the relevant literature. Background: Persistent…
  • 2026 International Congress

    Risk stratification study of fluid biomarkers for alpha-synucleinopathy with dementia

    R. Kamo, A. Okuzumi, H. Takeshige, N. Nishikawa, N. Hattori, T. Hatano (Bunkyo, Japan)

    Objective: This study focuses on mixed pathology of α-synucleinopathy and Alzheimer’s disease(AD), analyzing the relationships among biomarkers, genetic factors, and cognitive function in order to…
  • 2026 International Congress

    Data-driven Longitudinal Trajectories of Hippocampal Volume in Parkinson’s Disease and Across the Neurodegenerative Disease Spectrum

    U. Saeed, S. E Black, C. Marras, M. A Binns, D. P Breen, K. N Fishman, D. A Grimes, B. Levine, P. M Mclaughlin, A. K Troyer, R. Bartha, H. Zetterberg, A. E Lang, M. Masellis (Toronto, Canada)

    Objective: To elucidate hippocampal (HP) volume trajectories in Parkinson disease (PD) and across the neurodegenerative disease (NDD) spectrum. Background: HP volume is a critical neuroimaging…
  • 2026 International Congress

    Optimizing Institutional Long-Term Care in Advanced Parkinson’s and Other Neurodegenerative Disease: The OPTICARE Study

    J. Stuempel, J. Braun, J. Wolters, C. Woopen, B. Schmitz-Luhn (Bonn, Germany)

    Objective: To analyze and improve institutional long-term care (LTC) structures for patients with advanced PD and AD by identifying modifiable determinants of care integration, QoL,…
  • 2026 International Congress

    The Burden of Cognitive Impairment in People with Parkinson’s across Outpatients and Prevalent Patients in Coastal Kenya: A Transforming Parkinson’s Care in Africa (TraPCAf) Study

    R. Morton, S. Mwamba, D. Nyabuto, J. Nambafu, S. Kariuki, D. Sokhi, S. Ahmed, Y. Okkaoglu, C. Dotchin, C. Newton, N. Fothergill-Misbah, N. Okubadejo, R. Walker (Newcastle Upon Tyne, United Kingdom)

    Objective: To describe the rate and severity of cognitive impairment within the coastal Kenyan cohort of TraPCAf. Background: Cognitive impairment is a well-recognised non-motor symptom of PD, however there is very…
  • 2026 International Congress

    Spatiotemporal Trajectories of Plasma Biomarkers and Diffusion MRI Metrics in Parkinson’s Disease

    S. Ueno, H. Takeshige-Amano, S. Miyaguchi, K. Takabayashi, Y. Yada, Y. Kondo, D. Samayoa, E. Igami, T. Ogawa, S. Ueno, W. Sako, T. Tateishi, T. Hoshino, K. Kamagata, N. Hattori, N. Honda, T. Hatano (Tokyo, Japan)

    Objective: To investigate the spatiotemporal dynamics of multimodal biomarkers and their role in early prediction of cognitive decline. Background: Cognitive impairment is a major source…
  • 2026 International Congress

    Investigating the Link Between Alzheimer’s Disease Genetic Risk Variants and Parkinson’s Disease Cognitive Impairment: An Exploration of Genetic Overlap

    A. Zirra, S. Jasaityte, P. Dimartino, A. Deoliveira Franco, R. Torricelli, J. Kenny, I. Nakashidze, M. Mshvenieridze, S. Sopromadze, V. van Midden, L. Gilchrist, P. Proitsi, A. Noyce, M. Perinan (London, United Kingdom)

    Objective: To investigate whether variants from a large Alzheimer’s disease (AD) genome-wide association study (GWAS; Bellenguez et al. 2022) in Europeans - including 85,934 clinically…
  • 1
  • 2
  • 3
  • …
  • 39
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley